Presentation is loading. Please wait.

Presentation is loading. Please wait.

Coagulation monitoring and management of anticoagulation during cardiac assist device support  Dietmar Fries, MD, Petra Innerhofer, MD, Werner Streif,

Published byHarold Cannon Modified over 4 years ago

Similar presentations

Presentation on theme: "Coagulation monitoring and management of anticoagulation during cardiac assist device support  Dietmar Fries, MD, Petra Innerhofer, MD, Werner Streif,"— Presentation transcript:

1 Coagulation monitoring and management of anticoagulation during cardiac assist device support 
Dietmar Fries, MD, Petra Innerhofer, MD, Werner Streif, MD, Wolfgang Schobersberger, MD, Josef Margreiter, MD, Herwig Antretter, MD, Christoph Hörmann, MD  The Annals of Thoracic Surgery  Volume 76, Issue 5, Pages (November 2003) DOI: /S (03)

2 Fig 1 Thrombelastographic monitoring system (ROTEG) analysis: maximum clot firmness (squares; in mm) and alpha angle (diamonds) from 23 days after biventricular assist device system implantation until 1 week after heart transplantation. After introducing therapy with clopidogrel, maximum clot firmness and alpha angle decreased to normal values. (TX = treatment.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3 Fig 2 Results of platelet function analyzer examinations after biventricular assist device system implantation as well as after heart transplantation. Collagen/epinephrine coagulation time (CT) and adenosin diphosphate-CT were in the normal range despite aspirin therapy. Clotting times increased after introducing therapy with clopidogrel. Values normalized after heart transplantation was performed and clopidogrel therapy was terminated. (alp = alpha angle; CFT = clot formation time; EXTEG = thrombelastastographic analysis, activated with tissue thromboplastin; MCF = maximum clot firmness; roTEG = thrombelastic monitoring system.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

4 Fig 3 Demonstration of coagulation management over the whole period of treatment. (EPI-CT = collagen/epinephrine coagulation time [diamonds]; ADP-CT = coagulation time [squares].) (TX = treatment.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

5 Fig 4 Thrombelastographic monitoring system (ROTEG) tracing 23 days after biventricular assist device (BIVAD) implantation and 1 week after heart transplantation: detection of a hypercoagulable coagulation status by early onset and high amplitude on day 23 after BIVAD implantation; decrease in maximum clot firmness; and alpha angle back to normal values after heart transplantation. (ECMO = extracorporeal membrane oxygenation; LMW = low molecular weight; PFA = platelet function analyzer; TX = treatment.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

Download ppt "Coagulation monitoring and management of anticoagulation during cardiac assist device support  Dietmar Fries, MD, Petra Innerhofer, MD, Werner Streif,"

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Left ventricular assist system as a bridge to myocardial recovery

Left ventricular assist system as a bridge to myocardial recovery
Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease Visc Med 2016;32:241-248 - DOI:10.1159/000446304 Fig. 1. On the left side,

Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease Visc Med 2016;32: DOI: / Fig. 1. On the left side,
Outcome at 2 years of infants with congenital diaphragmatic hernia: a population-based study  Sophie M Jaillard, MD, Véronique Pierrat, MD, Angélina Dubois,

Outcome at 2 years of infants with congenital diaphragmatic hernia: a population-based study  Sophie M Jaillard, MD, Véronique Pierrat, MD, Angélina Dubois,
Peripheral Extracorporeal Membrane Oxygenation: Comprehensive Therapy for High- Risk Massive Pulmonary Embolism  Ramin Malekan, MD, Paul C. Saunders, MD,

Peripheral Extracorporeal Membrane Oxygenation: Comprehensive Therapy for High- Risk Massive Pulmonary Embolism  Ramin Malekan, MD, Paul C. Saunders, MD,
Stephen H. McKellar, MD, MSc, Stuart Abel, BS, Christopher L

Stephen H. McKellar, MD, MSc, Stuart Abel, BS, Christopher L
Left ventricular assist system as a bridge to myocardial recovery

Left ventricular assist system as a bridge to myocardial recovery
Extracorporeal membrane oxygenation for septic shock: Heroic futility?

Extracorporeal membrane oxygenation for septic shock: Heroic futility?
Triple Bridge to Simultaneous Heart and Kidney Transplantation

Triple Bridge to Simultaneous Heart and Kidney Transplantation
Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart  Hartmuth B Bittner, MD, PhD, Edward P Chen, MD,

Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart  Hartmuth B Bittner, MD, PhD, Edward P Chen, MD,
Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial  Evaldas Girdauskas,

Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial  Evaldas Girdauskas,
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Vinod H. Thourani, MD, Paul M. Kirshbom, MD, Kirk R

Vinod H. Thourani, MD, Paul M. Kirshbom, MD, Kirk R
Philip J Wolfson, MD  The Annals of Thoracic Surgery 

Philip J Wolfson, MD  The Annals of Thoracic Surgery 
Outcome of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation and Graft Recovery  Hartmuth B. Bittner, MD, PhD, Sven Lehmann, MD,

Outcome of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation and Graft Recovery  Hartmuth B. Bittner, MD, PhD, Sven Lehmann, MD,
LiQian Chen, MD, PhD, Arthur W

LiQian Chen, MD, PhD, Arthur W
Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.

Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.
Antimyosin Antibodies in Cardiac Rejection

Antimyosin Antibodies in Cardiac Rejection
Successful Bridge Through Transplantation With Berlin Heart Ventricular Assist Device in a Child With Failing Fontan  David M. Hoganson, MD, Umar S. Boston,

Successful Bridge Through Transplantation With Berlin Heart Ventricular Assist Device in a Child With Failing Fontan  David M. Hoganson, MD, Umar S. Boston,
CTSNet: a unique educational vehicle

CTSNet: a unique educational vehicle

Similar presentations

Ads by Google